Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation - Concepedia

Concepedia

Publication | Open Access

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

DOI Full Paper Access

87

Citations

44

References

2019

Year

Judith Wienke, Felicitas Bellutti Enders, Johan Lim, Jorre S. Mertens, Lucas L. van den Hoogen, Camiel A. Wijngaarde, Joo Guan Yeo, Alain Meyer, Henny G. Otten, Ruth Fritsch‐Stork,

Arthritis & Rheumatology

Abstract

In this study, galectin-9 and CXCL10 were validated as sensitive and reliable biomarkers for disease activity in juvenile DM. Implementation of these biomarkers into clinical practice as tools to monitor disease activity and guide treatment might facilitate personalized treatment strategies.

References

	Year	Citations

Page 1